Production (Stage)
Ekso Bionics Holdings, Inc.
EKSO
$0.2798
$0.00120.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.54M | 17.93M | 17.68M | 18.16M | 17.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.54M | 17.93M | 17.68M | 18.16M | 17.91M |
| Cost of Revenue | 8.18M | 8.41M | 8.52M | 8.75M | 8.88M |
| Gross Profit | 9.37M | 9.51M | 9.17M | 9.41M | 9.03M |
| SG&A Expenses | 16.69M | 16.69M | 17.05M | 17.21M | 18.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.01M | 28.39M | 29.36M | 30.13M | 31.83M |
| Operating Income | -10.46M | -10.46M | -11.68M | -11.97M | -13.92M |
| Income Before Tax | -10.79M | -11.33M | -11.13M | -12.42M | -14.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.79 | -11.33 | -11.13 | -12.42 | -14.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.79M | -11.33M | -11.13M | -12.42M | -14.24M |
| EBIT | -10.46M | -10.46M | -11.68M | -11.97M | -13.92M |
| EBITDA | -8.88M | -8.85M | -10.04M | -10.31M | -12.23M |
| EPS Basic | -0.49 | -0.57 | -0.65 | -0.79 | -0.97 |
| Normalized Basic EPS | -0.30 | -0.35 | -0.40 | -0.49 | -0.60 |
| EPS Diluted | -0.49 | -0.57 | -0.66 | -0.79 | -0.97 |
| Normalized Diluted EPS | -0.30 | -0.35 | -0.40 | -0.49 | -0.60 |
| Average Basic Shares Outstanding | 88.57M | 80.59M | 70.40M | 64.16M | 59.58M |
| Average Diluted Shares Outstanding | 88.57M | 80.59M | 70.40M | 64.16M | 59.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |